How effective is rituximab in refractory myasthenia gravis?

Rituximab in AChR subtype of myasthenia gravis: systematic review. Di Stefano V, Lupica A, Rispoli MG, Di Muzio A, Brighina F, Rodolico C. JNNP 2020; 91:392-395. Abstract Background: Myasthenia gravis (MG) is a chronic autoimmune disorder of the neuromuscular junction characterised by an autoantibody against acetylcholine receptor (AChR-Ab), autoantibody against muscle-specific kinase (MuSK-Ab), lipoprotein-related protein […]

via How effective is rituximab in refractory myasthenia gravis? — Neurochecklists Blog

Source link

Related posts

Author response: Behavioral interventions as a treatment for epilepsy: A multicenter randomized controlled trial


Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy


A Simple Beam of Light Could Catch Zika-Infected Mosquitoes


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World